Navigation Links
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. - ALXN
Date:1/13/2017

NEW YORK, Jan. 12, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Alexion Pharmaceuticals, Inc. securities (NASDAQ: ALXN) from February 10, 2014 through November 9, 2016, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Alexion investors under the federal securities laws.

To join the Alexion class action, go to http://rosenlegal.com/cases-991.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) Alexion employed improper sales practices with respect to Soliris; (2) consequently, Alexion's revenues from Soliris sales were unlikely to be sustainable; and (3) as a result, Alexion's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 17, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-991.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY  10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/equity-alert-rosen-law-firm-announces-filing-of-securities-class-action-lawsuit-against-alexion-pharmaceuticals-inc--alxn-300390607.html


'/>"/>
SOURCE Rosen Law Firm, P.A.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Boda
2. AuraSense Therapeutics Closes Tranche II of Series B Equity Investment
3. Otonomy Completes $45.9 Million Series C Equity Financing
4. Cyberonics Reports Inducement Equity Award Under NASDAQ Listing Rule 5635(c)(4)
5. SeeThruEquity, LLC Initiates Coverage on Pressure BioSciences, Inc.
6. Biocartis Poised for 2014 Commerical Launch with EUR 30 Million Series E Equity Fundraising
7. Aethlon Medical to Present at SeeThruEquity Investor Conference
8. Pressure BioSciences, Inc. Discusses Record Third Quarter Revenue, Strong Fourth Quarter Guidance, Significant Progress on New Instrument Systems, and Expectation to Pay-Off All Outstanding Convertible Notes at the SeeThruEquity Financial Conference
9. Atonomics and OMRON Healthcare Enter Agreement for Equity Investment
10. Pharmagen Partners with Bagel Boy Equity Group II, LLC and prepares to Launch its Industry Consolidation Strategy
11. Echo Therapeutics to Present at the Noble Financial Capital Markets Tenth Annual Equity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/19/2019)... ... July 19, 2019 , ... Cloudticity, ... of Chris Whaley as Senior Vice President of Business Development. , Whaley ... experience better using cloud technology. , As a technology leader with more than ...
(Date:7/19/2019)... ... July 19, 2019 , ... Robinson Pharma, Inc., is proud to ... facilities was audited by the Safe Quality Food (SQF) Institute using an accredited certification ... Safety Code for Manufacturing, Edition 8. , The SQF Certification program is trusted by ...
(Date:7/18/2019)... ... July 18, 2019 , ... ComplianceLine, the ... 20 years, announced today it is moving into new corporate headquarters in Charlotte ... are thrilled to be moving into the new office which will allow our ...
Breaking Medicine Technology:
(Date:7/18/2019)... , ... July 18, 2019 , ... Gateway Genomics ... children, announces a new publication titled, “ Accurate Fetal Sex Determination from Maternal Blood ... In the study, DNA blood samples were collected from 108 women at an average ...
(Date:7/17/2019)... ... July 17, 2019 , ... The ... online Family Nurse Practitioner program. The honor is given to distance learning courses ... , The Catalyst Awards honor institutions from around the world that produce exemplary ...
(Date:7/17/2019)... SAINT PAUL, Minn. (PRWEB) , ... July 17, ... ... created to assist healthcare providers working with the ICD-10 coding set, is launching ... listeners Continuing Education Units (CEUs) at no additional charge, officials announced this week. ...
(Date:7/17/2019)... YORK (PRWEB) , ... July 17, 2019 , ... A ... the Journal of the American Medical Association (JAMA), shows for the first ... sepsis deaths in the state. Sepsis is the body’s extreme response to infection. It ...
(Date:7/17/2019)... ... , ... Dr. Jonathan Zaidan, MD, FACOG, President of Women’s Excellence discusses a ... The show airs on Wednesday, July 17ths at 7pm. The show podcast will ... Ann Thomas discuss the challenges that women face when it comes to weight loss ...
Breaking Medicine News(10 mins):